stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Filing Summaries
    stockgist
    HomeTop MoversCompaniesConcepts

    AI-Generated Filing Summaries

    AI-powered insights from 8-K, 6-K, 10-K and 10-Q filings with category and key takeaways

    Past 24 Hours

    Total

    430

    10-K

    13

    10-Q

    10

    8-K

    239

    6-K

    145

    13F

    0

    Other

    23

    Materiality:

    Showing 30 of 15950 summaries

    Highlander Silver Corp.

    6-K

    Filing ID: 791777 • Apr 2, 2026, 4:50 PM ET

    Shareholder Meeting Notice
    LOW
    5.07
    •

    Annual General Meeting scheduled for June 25, 2026 — sets timeline for shareholder governance actions including director elections and auditor ratification.

    •

    Record date for notice and voting is April 30, 2026 — determines eligibility to receive proxy materials and vote at the meeting.

    •

    Notice-and-access delivery method used for both registered holders and beneficial owners — indicates cost-efficient, electronic-first proxy distribution compliant with SEC rules.

    Highlander Silver Corporation announced its Annual General Meeting of shareholders will be held on June 25, 2026, with a record date of April 30, 2026, for both notice and voting; the Company will use notice-and-access for proxy materials delivery to registered holders and beneficial owners.

    View Filing

    Iron Horse Acquisitions Corp. II Units

    IRHOU
    10-Q

    Filing ID: 791771 • Apr 2, 2026, 4:40 PM ET

    •

    Reported net income of $1.4 million was driven by interest earned on funds held in trust, offset by operational costs, highlighting the financial profile of a SPAC in its search phase.

    •

    Operating activities used $473,126 in cash, reflecting the costs incurred while evaluating potential acquisition targets, with a portion attributable to changes in operating assets and liabilities.

    •

    The company completed its Initial Public Offering in the prior quarter, generating substantial capital that is held in trust to fund a future Business Combination.

    The quarter reflects the company's pre-acquisition stage, with net income driven by trust account interest while operating activities consumed cash. Management believes current resources are sufficient to fund the ongoing search for a Business Combination.

    View Filing

    ReNew Energy Global plc

    RNWWW
    6-K

    Filing ID: 791776 • Apr 2, 2026, 4:40 PM ET

    Investment in Subsidiary Platform
    MEDIUM
    •

    ReNew Green received ~INR 8.83 billion (US$95 million) proceeds from LeapFrog-led consortium on April 2, 2026.

    •

    Consortium acquires 11.3% shareholding in ReNew Green.

    •

    ReNew Green's portfolio has 2.5 GW committed capacity for C&I customers, with over 2.0 GW commissioned.

    ReNew Energy Global Plc's commercial and industrial platform ReNew Green received INR 8.83 billion (US$95 million) investment proceeds from a LeapFrog-led consortium, acquiring 11.3% shareholding.

    View Filing

    ReNew Energy Global plc

    RNW
    6-K

    Filing ID: 791776 • Apr 2, 2026, 4:40 PM ET

    Investment in Subsidiary Platform
    MEDIUM
    •

    ReNew Green received ~INR 8.83 billion (US$95 million) proceeds from LeapFrog-led consortium on April 2, 2026.

    •

    Consortium acquires 11.3% shareholding in ReNew Green.

    •

    ReNew Green's portfolio has 2.5 GW committed capacity for C&I customers, with over 2.0 GW commissioned.

    ReNew Energy Global Plc's commercial and industrial platform ReNew Green received INR 8.83 billion (US$95 million) investment proceeds from a LeapFrog-led consortium, acquiring 11.3% shareholding.

    View Filing

    Plus Therapeutics, Inc.

    PSTV
    8-K

    Filing ID: 791774 • Apr 2, 2026, 4:40 PM ET

    Reverse Stock Split
    MEDIUM
    3.03
    5.03
    •

    Reverse stock split at 1-for-25 ratio approved by stockholders on August 7, 2025, and Board-fixed on March 20, 2026.

    •

    Effective at 12:01 a.m. ET on April 2, 2026; trading on Nasdaq under PSTV with new CUSIP 72941H806.

    •

    Outstanding shares reduced from ~171.6 million to ~6.86 million pre-split shares.

    Plus Therapeutics, Inc. implemented a 1-for-25 reverse stock split effective April 2, 2026, reducing outstanding common shares from approximately 171,550,698 to 6,862,027 to meet Nasdaq's $1.00 minimum bid price requirement.

    View Filing

    ALPHATIME ACQUISITION CORP

    8-K

    Filing ID: 791773 • Apr 2, 2026, 4:40 PM ET

    Business Combination Extension and Shareholder Vote
    HIGH
    1.01
    2.03
    5.03
    5.07
    •

    Shareholders approved extending the business combination deadline from April 4, 2026, to December 4, 2026, allowing up to eight one-month extensions.

    •

    The Company must deposit $15,000 into the trust account for each monthly extension, funded via unsecured promissory notes.

    •

    Holders of 6,135 ordinary shares elected to redeem their shares, resulting in a $79,480.65 distribution from the trust account.

    AlphaTime Acquisition Corp shareholders approved an extension of the business combination deadline to December 4, 2026, with 6,135 shares redeemed, leaving $4.76 million in the trust account.

    View Filing

    NaaS Technology Inc.

    NAAS
    6-K

    Filing ID: 791772 • Apr 2, 2026, 4:40 PM ET

    Extraordinary General Meeting - Authorized Share Capital Increase
    MEDIUM
    •

    EGM scheduled for April 29, 2026 at 10:30 AM Beijing time in Langfang City, Hebei Province.

    •

    Proposes increasing authorized share capital by US$317,200 to US$369,200, creating 317,200,000,000 additional Class A ordinary shares.

    •

    Record date: close of business April 3, 2026 (Cayman Islands time for shares, New York time for ADSs).

    NaaS Technology Inc. announced an Extraordinary General Meeting on April 29, 2026 to approve increasing authorized share capital from US$52,000 to US$369,200, primarily by adding 317.2 billion Class A ordinary shares.

    View Filing

    Vanda Pharmaceuticals Inc.

    VNDA
    8-K

    Filing ID: 791769 • Apr 2, 2026, 4:40 PM ET

    Executive Change
    MEDIUM
    5.02
    •

    Timothy Williams resigned from his role as Senior Vice President, General Counsel and Secretary, a key legal and corporate governance position.

    •

    Resignation is effective April 10, 2026, providing the company with a 12-day transition window following notification on March 29, 2026.

    •

    The filing states Williams is departing 'to pursue other endeavors', with no disclosure of disagreement, misconduct, or involvement in financial reporting issues.

    Timothy Williams resigned as Senior Vice President, General Counsel and Secretary of Vanda Pharmaceuticals Inc., effective April 10, 2026, to pursue other endeavors.

    View Filing

    South Bow Corporation

    SOBO
    6-K

    Filing ID: 791768 • Apr 2, 2026, 4:40 PM ET

    Annual General Meeting Materials
    MEDIUM
    •

    Annual General Meeting scheduled for May 7, 2026 at 8:00 a.m. Mountain time via virtual LUMI platform.

    •

    11 directors nominated for election, including CEO Bevin Wirzba; 10 independent if elected.

    •

    KPMG LLP appointed auditor since October 1, 2024; billed C$3.94M in 2025 vs C$1.79M in 2024.

    South Bow Corporation filed its 2026 Management Information Circular for the virtual Annual General Meeting on May 7, 2026, seeking shareholder approval for election of 11 directors, appointment of KPMG LLP as auditors, and advisory vote on executive compensation.

    View Filing

    Intrepid Potash, Inc.

    IPI
    8-K

    Filing ID: 791761 • Apr 2, 2026, 4:40 PM ET

    Asset Disposition and Credit Agreement Amendment
    HIGH
    1.01
    2.01
    2.03
    7.01
    •

    Intrepid Potash-New Mexico, LLC sold the Intrepid South Ranch to HydroSource Logistics, LLC for $70.0 million in cash, including an $8.0 million deposit received in December 2025 — proceeds represent acceleration of decades of future cash flow.

    •

    The Ranch Assets include ~21,793 acres of fee land, ~27,858 acres of federal grazing leases, associated water rights, and other assets — constituting the majority of the company’s oilfield solutions segment.

    •

    The Credit Agreement was amended to extend its maturity date from its prior term to March 30, 2031, enhancing near- and medium-term debt maturity profile.

    Intrepid Potash, Inc. completed the $70.0 million cash sale of its Intrepid South Ranch assets on April 1, 2026, comprising the majority of its oilfield solutions segment, and concurrently amended its credit agreement to extend maturity to March 30, 2031 and appoint BMO Bank N.A. as successor administrative agent.

    View Filing

    Millicom International Cellular S.A.

    TIGO
    6-K

    Filing ID: 791767 • Apr 2, 2026, 4:40 PM ET

    Debt Reopening / Additional Notes Pricing
    MEDIUM
    •

    Priced $75 million aggregate principal of 7.375% Senior Notes due 2032 at 100.985% plus accrued interest.

    •

    Additional Notes reopen existing series originally issued April 2, 2024; $450 million Notes currently outstanding.

    •

    Expected closing April 14, 2026, subject to customary conditions.

    Millicom priced $75 million of additional 7.375% Senior Notes due 2032 at 100.985% in a Regulation S private placement, reopening its existing issuance with $450 million currently outstanding.

    View Filing

    Gulf Resources, Inc.

    GURE
    8-K

    Filing ID: 791766 • Apr 2, 2026, 4:40 PM ET

    Private Placement Equity Financing
    HIGH
    1.01
    3.02
    •

    Entered four Private Placement Agreements on January 26, March 5, March 19, and March 28, 2026 with four individual investors.

    •

    Issued aggregate 274,000 shares representing approximately 18% of shares outstanding as of December 31, 2025.

    •

    January 26 deal: 69,000 shares for US$246,330 at 90% of 5-day average closing price.

    Gulf Resources, Inc. entered into four private placement agreements in January and March 2026 to issue approximately 18% of its outstanding shares to individual investors to enhance liquidity and market value.

    View Filing

    Alcon Inc.

    ALC
    6-K

    Filing ID: 791763 • Apr 2, 2026, 4:40 PM ET

    Annual General Meeting Agenda
    MEDIUM
    •

    Alcon's 2026 AGM scheduled for April 30, 2026 in Lausanne, fourth in-person since independence.

    •

    Board proposes electing R. Scott Herren, former Cisco CFO, as new independent director.

    •

    Proposed gross dividend of CHF 0.28 per share, ex-dividend May 5/6, 2026, payable around May 7.

    Alcon Inc. published the agenda for its 2026 AGM on April 30, proposing election of R. Scott Herren as new independent director and CHF 0.28 per share dividend.

    View Filing

    Booking Holdings Inc.

    BKNG
    8-K

    Filing ID: 791762 • Apr 2, 2026, 4:40 PM ET

    Stock Split and Charter Amendment
    MEDIUM
    5.03
    •

    A twenty-five-for-one forward stock split was effected, automatically subdividing each outstanding share into 25 shares.

    •

    Authorized common stock increased proportionally from 1,000,000,000 shares to 25,000,000,000 shares.

    •

    The amendment became effective at 4:01 p.m. Eastern Time on April 2, 2026.

    Booking Holdings Inc. filed an amendment to its Restated Certificate of Incorporation to effect a 25-for-1 forward stock split, increasing authorized common shares to 25 billion.

    View Filing

    Mativ Holdings, Inc.

    MATV
    8-K

    Filing ID: 791760 • Apr 2, 2026, 4:40 PM ET

    Executive Departure
    MEDIUM
    5.02
    •

    Ryan Elwart, Group President, tendered resignation on March 30, 2026.

    •

    Resignation effective April 27, 2026.

    •

    Departure to pursue other opportunities.

    Mativ Holdings, Inc. announced the resignation of Group President Ryan Elwart, effective April 27, 2026, to pursue other opportunities.

    View Filing

    Weatherford International plc

    WFRD
    8-K

    Filing ID: 791759 • Apr 2, 2026, 4:40 PM ET

    Corporate Redomestication Proposal
    MEDIUM
    •

    The Company proposes to reorganize by moving its parent company domicile from Ireland to the United States (Texas).

    •

    The redomestication is expected to be completed in the third quarter of 2026, subject to shareholder and court approvals.

    •

    Strategic rationale includes simplifying corporate structure, reducing compliance costs, and broadening the potential lender base.

    Weatherford International plc announced a proposal to redomesticate its parent company from Ireland to the United States, specifically Texas, aiming to streamline corporate structure and enhance capital management flexibility.

    View Filing

    Strategic Storage Trust VI, Inc.

    8-K

    Filing ID: 791758 • Apr 2, 2026, 4:40 PM ET

    Earnings Release
    HIGH
    2.02
    7.01
    •

    Total revenues increased $2.5 million (8.8%) to $30.7 million for the year ended December 31, 2025 — reflects continued same-store growth and new asset contributions.

    •

    Same-store revenues rose 4.6% and same-store NOI increased 8.6%, while same-store occupancy declined 1.0 percentage points to 90.3% — indicates pricing power offsetting modest occupancy softness.

    •

    Net loss attributable to common stockholders decreased $10.7 million (22.7%) to $36.6 million — driven by lower acquisition expenses and improved operating leverage.

    Strategic Storage Trust VI, Inc. reported year-ended December 31, 2025 financial results showing $30.7 million in total revenues (up 8.8% YoY), a $36.6 million operating loss, and a $36.6 million net loss attributable to common stockholders, alongside progress on Canadian development projects and an updated $10.00 estimated NAV per share.

    View Filing

    Navan, Inc.

    NAVN
    10-K

    Filing ID: 791755 • Apr 2, 2026, 4:40 PM ET

    •

    Revenue reached $702.3M as platform engagement grew, with dedicated customer success teams educating customers on full offerings to maximize efficiency across travel and expense workflows.

    •

    Gross margin reached 71.3% primarily due to revenue increase on relatively fixed cost base, enabled by AI-powered customer support delivery.

    •

    Operating income was -$196.9M (-28.0% margin), reflecting increased salaries and benefits driven by stock-based compensation from IPO and headcount growth to support expansion.

    Navan achieved $702.3M revenue and 71.3% gross margin through revenue scale on a relatively fixed cost base supported by AI-powered customer support, generating $32.8M positive free cash flow despite operating loss from IPO-related stock compensation and growth investments.

    View Filing

    Harmonic Inc.

    HLIT
    8-K

    Filing ID: 791757 • Apr 2, 2026, 4:40 PM ET

    Director Resignation
    MEDIUM
    5.02
    •

    Dan Whalen resigned from Harmonic’s Board of Directors effective March 31, 2026.

    •

    Resignation due to potential conflicts from new role at another company.

    •

    No disagreement with Harmonic on operations, policies, or practices.

    Harmonic Inc. director Dan Whalen resigned from the Board effective March 31, 2026, due to potential conflicts from a new role at another company, with no disagreements on company matters.

    View Filing

    PharmaCyte Biotech, Inc.

    PMCB
    8-K

    Filing ID: 791754 • Apr 2, 2026, 4:30 PM ET

    Shareholder Vote on Equity Plan Amendment and Reverse Stock Split
    HIGH
    5.02
    5.07
    •

    Shareholders approved a 2,000,000-share increase to the 2022 Equity Incentive Plan, raising total authorized shares to 7,000,000 — expanding dilution potential and equity compensation capacity.

    •

    A reverse stock split authorization (1-for-1.1 to 1-for-100) was approved, granting the Board discretion to implement it without further shareholder vote — signaling possible future compliance or market eligibility actions.

    •

    Five directors were elected, all receiving majority 'For' votes, though each faced significant 'Withheld' votes (372,794–550,006), indicating notable dissent among participating shareholders.

    PharmaCyte Biotech, Inc. obtained shareholder approval at its March 30, 2026 Annual Meeting to amend its 2022 Equity Incentive Plan by adding 2,000,000 shares and to authorize a reverse stock split of up to 1-for-100, alongside electing five directors and ratifying its auditor.

    View Filing

    IRIDEX Corporation

    IRIX
    10-K

    Filing ID: 791752 • Apr 2, 2026, 4:30 PM ET

    •

    Revenue reached $52.7 million, but the company reported a net loss of $4.4 million and negative diluted EPS of $0.26, indicating continued profitability challenges.

    •

    Gross margin was 36.5%, with management attributing the decline to inventory write-downs, increased product costs from tariffs, and lower capitalization of manufacturing overhead.

    •

    Operating loss was $2.6 million, an improvement attributed to implemented cost savings measures that resulted in lower headcount and other expenses.

    IRIDEX Corporation reported a challenging fiscal year 2026, with revenue of $52.7 million resulting in an operating loss of $2.6 million and a net loss of $4.4 million. The company's financial performance reflects margin pressures and ongoing cash consumption, though cost-saving initiatives contributed to operational improvements.

    View Filing

    Charming Medical Ltd

    6-K

    Filing ID: 791753 • Apr 2, 2026, 4:30 PM ET

    Director Appointment
    MEDIUM
    •

    Matthew Mo Kan Tsui appointed as Independent Director, bringing over 20 years of accounting and finance experience.

    •

    Mr. Tsui will serve as Chairman of the Audit Committee and member of both the Compensation and Nominating Committees.

    •

    Annual compensation for the directorship is set at HK$384,000, payable monthly.

    Charming Medical Limited appointed Matthew Mo Kan Tsui as an Independent Director, Audit Committee Chairman, and Compensation and Nominating Committee member effective April 2, 2026.

    View Filing

    Cheetah Net Supply Chain Service Inc.

    CTNT
    8-K

    Filing ID: 791751 • Apr 2, 2026, 4:30 PM ET

    Material Definitive Agreement
    HIGH
    1.01
    •

    Entered into a $100 million ATM sales agreement with AC Sunshine Securities LLC on March 31, 2026 — establishes flexible equity capital access mechanism.

    •

    Up to $70 million of shares will be offered under the April 2, 2026 ATM Prospectus Supplement to Form S-3 (File No. 333-281820) — confirms immediate regulatory eligibility for offerings.

    •

    Sales Agent receives 3.0% commission on gross proceeds and is reimbursed up to $100,000 for initial offering expenses — defines cost structure and upfront financial commitment.

    Cheetah Net Supply Chain Service Inc. entered into a $100 million at-the-market (ATM) sales agreement with AC Sunshine Securities LLC on March 31, 2026, enabling the company to sell Class A common stock from time to time at its discretion, subject to regulatory and contractual conditions.

    View Filing

    Esperion Therapeutics, Inc.

    ESPR
    8-K

    Filing ID: 791747 • Apr 2, 2026, 4:30 PM ET

    Acquisition and Financing
    HIGH
    1.01
    2.01
    2.03
    •

    Acquired Corstasis Therapeutics for $75M upfront cash, plus up to $180M in regulatory/commercial milestones and future royalty payments.

    •

    Amended existing credit facility to add $25M in term loans to fund the acquisition, with prepayment penalties for early repayment.

    •

    Sold $50M of future royalties from Otsuka collaboration to Athyrium, which will receive payments until $100M is collected before rights revert.

    Esperion Therapeutics completed the acquisition of Corstasis Therapeutics for $75 million upfront, funded by a $25 million term loan amendment and a $50 million royalty sale, expanding its cardiovascular portfolio with the nasal spray diuretic Enbumyst.

    View Filing

    Iris Acquisition Corp II

    IRAB
    8-K

    Filing ID: 791748 • Apr 2, 2026, 4:30 PM ET

    Amendment to Administrative Services Agreement
    LOW
    1.01
    •

    Entered first amendment to Administrative Services Agreement dated February 2, 2026, effective March 30, 2026.

    •

    Sponsor or affiliate to provide office space at Unit OT 09-31, Central Park Towers, DIFC, Dubai for $20,000 monthly.

    •

    Accrued fees for February and March 2026 totaling $40,000 redirected to Sponsor Affiliate.

    Iris Acquisition Corp II amended its Administrative Services Agreement with sponsor Iris Acquisition Holdings II LLC to provide office space via sponsor affiliate at $20,000 per month and redirect $40,000 accrued fees.

    View Filing

    Tyson Foods, Inc.

    TSN
    8-K

    Filing ID: 791746 • Apr 2, 2026, 4:30 PM ET

    Executive Change
    MEDIUM
    5.02
    •

    Phillip Thomas is appointed Vice President, Controller and Chief Accounting Officer effective April 6, 2026 — a key finance leadership role overseeing financial reporting and controls.

    •

    Lori Bondar steps down as Chief Accounting Officer but remains Senior Vice President to support transition and plans to retire before fiscal year-end.

    •

    Thomas’ annual base salary is $360,574, with a target annual incentive of 55% of base salary and long-term incentive target of $175,000 (75% RSUs, 25% performance stock).

    Tyson Foods, Inc. announced the appointment of Phillip Thomas as Vice President, Controller and Chief Accounting Officer effective April 6, 2026, succeeding Lori Bondar, who will retire prior to fiscal year-end after assisting with the transition.

    View Filing

    Invech Holdings, Inc.

    S-1

    Filing ID: 791744 • Apr 2, 2026, 4:30 PM ET

    •

    The company acquired the SaaS rental platform www.paragonrentals.ai on March 3, 2026, for a $450,000 convertible promissory note — its sole current operating asset.

    •

    It generated zero revenue in both 2025 and 2024 and reported net losses of $58,018 and $60,475, respectively, with no cash on hand as of December 31, 2025.

    •

    The S-1 registers 30,000,000 shares of common stock for resale by GHS Investments LLC under an equity financing agreement, not for primary proceeds to the company.

    Invech Holdings, Inc. is a Nevada-based holding company pivoting to SaaS platform development and public company compliance consulting, with no revenue to date and a high-risk capital structure centered on a $10M equity line of credit with GHS Investments LLC.

    View Filing

    Black Hills Corporation

    BKH
    8-K

    Filing ID: 791745 • Apr 2, 2026, 4:30 PM ET

    Shareholder Vote Results and Merger Update
    HIGH
    5.07
    7.01
    •

    Shareholders approved the issuance of shares for the merger with NorthWestern Energy, with 59.8 million votes for and 1.5 million against.

    •

    Shareholders approved increasing authorized shares from 100 million to 300 million, with 61.3 million votes for and 5.7 million against.

    •

    Shareholders approved changing the company name, with 65.1 million votes for and 1.8 million against.

    Black Hills Corporation shareholders approved all six proposals at a special meeting on April 2, 2026, including the issuance of shares for the merger with NorthWestern Energy, which remains subject to regulatory approvals and is expected to close in the second half of 2026.

    View Filing

    BBB Foods Inc.

    TBBB
    20-F

    Filing ID: 791740 • Apr 2, 2026, 4:30 PM ET

    •

    Revenue growth was primarily driven by an increase in sales, partially offset by a decrease in the cardboard price per ton, reflecting both market demand and input cost dynamics.

    •

    The company's net loss was influenced by significant share-based compensation expenses and strategic investments in new regions and talent, aligning with its growth trajectory.

    •

    Operating cash flow strengthened, supporting capital expenditures for store openings, renovation of existing stores and distribution centers, acquisitions of equipment, and software investments.

    BBB Foods Inc. navigated a challenging fiscal year marked by aggressive growth investments and strategic expenses, resulting in a net loss despite strong revenue expansion and operational cash generation. The company's performance reflects its ongoing commitment to store expansion and infrastructure development.

    View Filing

    Consumer Portfolio Services, Inc.

    CPSS
    8-K

    Filing ID: 791742 • Apr 2, 2026, 4:30 PM ET

    Executive Compensation Disclosure
    MEDIUM
    5.02
    •

    The Compensation Committee approved final FY2025 non-equity incentive plan payments for named executive officers.

    •

    CEO Charles E. Bradley, Jr.'s total compensation for FY2025 was $5,439,647, including a non-equity incentive payment of $3,283,500.

    •

    President & COO Michael T. Lavin's total FY2025 compensation was $1,386,590, with a non-equity incentive payment of $448,693.

    Consumer Portfolio Services, Inc. filed an 8-K on April 2, 2026, to disclose the final non-equity incentive plan compensation payments for its named executive officers for fiscal year 2025, which were omitted from its prior 10-K filing.

    View Filing
    1...35...532
    Go toof 532

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice